The rapid development of the COVID 19 vaccine has both its promoters and detractors. Regardless where one might fall on this spectrum there are many who may wonder what changes were made in the pharmaceutical development process that enabled the COVID 19 vaccine to rapidly come to market. In this episode we explore the pharmaceutical development process and merits of the COVID 19 vaccine with Keith Watts DBA, Principal of pharmaceutical and healthcare consulting organization Talexto Health Care Strategies.
Watch Previous Episodes And Listen To Previous Podcasts:
*** https://satisfactionist.com/satisfactionist-show-page/ ***
Apple
https://podcasts.apple.com/us/podcast/satisfactionist-live/id1111996307
Spotify
https://open.spotify.com/show/4UoIcUaJXqyoo9NDnh3qZJ?si=rXBn6rzKSKi07G81c-lWNw
Support The Show:
*** https://satisfactionist.com/merch-shop/ ***
Content Production Gear:
Video:
Canon 80D: https://amzn.to/2UzFoBl
Canon 18-55mm: https://amzn.to/36NmOLI
Canon 50mm: https://amzn.to/3nIK04W
Rokinon 85mm t1.5: https://amzn.to/3pvMS6G
Apature Amaran AL-F7 (x2): https://amzn.to/3lA47Bs
Audio
Steinberg UR242: https://amzn.to/2INjZ5n
Sure SM58: https://amzn.to/3kybvfq
Rode VideoMic: https://amzn.to/38RRm1u
Zoom H6: https://amzn.to/3pFalCm
Tascam DL-10: https://amzn.to/3nyUTGk
Editing
ViewSonic (x2): https://amzn.to/38NmxLD
MacBook Pro: https://amzn.to/2INkCMh